€23.30
0.85%
Xetra, Sep 25, 05:35 pm CEST. Closed.
ISIN
DE000A0MSN11
Symbol
M7U
Index

Nynomic Stock price

€23.30
+0.70 3.10% 1M
+11.15 91.77% 6M
+13.46 136.79% YTD
+12.75 120.85% 1Y
-8.20 26.03% 3Y
-24.90 51.66% 5Y
+15.91 215.25% 10Y
+13.79 145.01% 20Y
Xetra, Closing price Fri, Sep 25 2026
-0.20 0.85%
ISIN
DE000A0MSN11
Symbol
M7U
Index

Is Nynomic a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
€162.3m
Enterprise Value
€165.9m
Net debt
€3.6m
Cash
€14.0m
Shares outstanding
6.6m
Valuation (TTM | estimate)
P/E
46.1
P/S
1.7 | 1.5
EV/Sales
1.7 | 1.5
EV/FCF
22.8
P/B
1.7
Financial Health
Equity Ratio
72.0%
Return on Equity
-0.7%
ROCE
5.1%
ROIC
4.5%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
€98.2m | €107.0m
EBITDA
€12.0m
EBIT
€5.8m
Net Income
€3.3m
Free Cash Flow
€7.3m
Growth (TTM | estimate)
Revenue
1.3% | 15.6%
EBITDA
79.1%
EBIT
389.6%
Net Income
150.1%
Free Cash Flow
184.7%
Margin
Gross
63.9%
EBITDA
12.2%
EBIT
5.9%
Net
3.4%
Free Cash Flow
7.4%
More
EPS
€0.5
FCF per Share
€1.1
Short interest
-
Employees
548
Rev per Employee
€170.0k

Nynomic Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Nynomic forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Nynomic forecast:

Buy
83%
Hold
17%

Financial data from Nynomic

Jun '26
+/-
%
98 98
1% 1%
100%
- Direct Costs 35 35
1% 1%
36%
63 63
2% 2%
64%
- Selling and Administrative Expenses 39 39
8% 8%
40%
- Research and Development Expense - -
-
-
12 12
79% 79%
12%
- Depreciation and Amortization 6.17 6.17
12% 12%
6%
EBIT (Operating Income) EBIT 5.81 5.81
390% 390%
6%
Net Profit 3.33 3.33
150% 150%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Nynomic directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Nynomic AG engages in the manufacture of products for optical metrology. It operates through the following business segments: Life Science, Green Tech, Clean Tech, and Other. The Life Science segment offers products in the field of medical technology and laboratory automation. The Green Tech segment provides solutions for agriculture and environmental technology. The Clean Tech segment focuses on the areas of application throughout the industrial sector. The company was founded by Hans Wörmcke and Sascha Otto on June 1, 1995 and is headquartered in Wedel, Germany.

Head office Germany
CEO Maik Peters
Employees 548
Founded 1995
Website www.nynomic.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today